Zhu D Z, Cheng C F, Pauli B U
Department of Pathology, Cornell University College of Veterinary Medicine, Ithaca, NY 14853.
Proc Natl Acad Sci U S A. 1991 Nov 1;88(21):9568-72. doi: 10.1073/pnas.88.21.9568.
Organ-specific adhesion molecules expressed by vascular endothelial cells have been implicated in the arrest of blood-borne cancer cells in selective, secondary sites. A lung-specific endothelial cell adhesion molecule (Lu-ECAM-1) localized on endothelia of distinct branches of lung blood vessels has been purified by immunoaffinity chromatography from detergent extracts of lung matrix-modulated endothelial cells using monoclonal antibody (mAb) 6D3. It has a molecular mass of 90 kDa and promotes the selective attachment of lung-metastatic B16 melanoma cells. Corresponding with their metastatic performance, B16-F10 tumor cells selected for higher lung colonization bind to Lu-ECAM-1 in significantly higher numbers than their low lung metastatic counterpart B16-F0. Binding of B16-F0 and B16-F10 is reduced with mAb 6D3 to slightly lower levels than B16-F0 bound to Lu-ECAM-1. mAb 6D3 injected into C57BL/6 mice 1 hr prior to an i.v. challenge with B16-F10 causes a 90% reduction in the number of lung colonies compared with animals injected with control mAb (6D8 or 3C6). Lu-ECAM-1 neither binds nor effects metastasis of other lung-colonizing tumor cells (e.g., KLN205). Thus, site-specific metastasis of tumor cells is regulated by similar mechanisms as the homing of lymphocytes--namely, by the ability of blood-borne cancer cells to recognize and adhere to distinct endothelial cell adhesion molecules.
血管内皮细胞表达的器官特异性黏附分子与血源性癌细胞在选择性的继发部位的滞留有关。一种位于肺血管不同分支内皮上的肺特异性内皮细胞黏附分子(Lu-ECAM-1),已使用单克隆抗体(mAb)6D3通过免疫亲和层析从肺基质调节的内皮细胞的去污剂提取物中纯化出来。它的分子量为90 kDa,并促进肺转移性B16黑色素瘤细胞的选择性附着。与它们的转移性能相对应,选择用于更高肺定植的B16-F10肿瘤细胞与Lu-ECAM-1结合的数量明显高于其低肺转移对应物B16-F0。用mAb 6D3处理后,B16-F0和B16-F10的结合减少到略低于与Lu-ECAM-1结合的B16-F0的水平。在静脉注射B16-F10攻击前1小时向C57BL/6小鼠注射mAb 6D3,与注射对照单克隆抗体(6D8或3C6)的动物相比,肺集落数量减少了90%。Lu-ECAM-1既不结合也不影响其他肺定植肿瘤细胞(例如KLN205)的转移。因此,肿瘤细胞的位点特异性转移是由与淋巴细胞归巢类似的机制调节的——即血源性癌细胞识别并黏附于不同内皮细胞黏附分子的能力。